Rhinomed Ltd
ASX:RNO
Rhinomed Ltd
ASX:RNO
Price:
0.04 AUD
Market Closed
Updated:
Apr 30, 2024
Rhinomed Ltd
Cash from Investing Activities
|
Rhinomed Ltd
Cash from Investing Activities Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rhinomed Ltd
ASX:RNO
|
Cash from Investing Activities
-AU$95.3k
|
CAGR 3-Years
-172%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Cash from Investing Activities
AU$473.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Cash from Investing Activities
-AU$211.5m
|
CAGR 3-Years
-3 179%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-171%
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Cash from Investing Activities
-AU$16.7m
|
CAGR 3-Years
-902%
|
CAGR 5-Years
-332%
|
CAGR 10-Years
N/A
|
|
|
Probiotec Ltd
ASX:PBP
|
Cash from Investing Activities
-AU$14.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Cash from Investing Activities
AU$3.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rhinomed Ltd's Cash from Investing Activities?
Cash from Investing Activities
-95.3k
AUD
-95.3k
AUD
Based on the financial report for Jun 30, 2023, Rhinomed Ltd's Cash from Investing Activities amounts to -95.3k AUD.
What is Rhinomed Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-52%
-52%
Over the last year, the Cash from Investing Activities growth was 89%. The average annual Cash from Investing Activities growth rates for Rhinomed Ltd have been -172% over the past three years , -52% over the past five years .
You don't have any saved screeners yet
